NCT02452996View on ClinicalTrials.gov

Safety Study of GNbAC1 Monoclonal Antibody in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Healthy Volunteers
Interventions
DRUG

GNbAC1

Single dose of IMP, IV infusion

Trial Locations (1)

14050

PAREXEL Early Phase Clinical Unit, Berlin

Sponsors
All Listed Sponsors
lead

GeNeuro Innovation SAS

INDUSTRY